Evidence map›Paper›PMID 35241625›Full record

ArticleGut2023

Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation.

Luz Del Carmen Martínez-Sánchez, Phuong Anh Ngo, Rashmita Pradhan, Lukas-Sebastian Becker, David Boehringer, Despina Soteriou, Marketa Kubankova, Christine Schweitzer, Tatyana Koch, Veronika Thonn and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Temporal transcriptomic profiling identifies core regulators in cytokine-induced gut barrier disruption in differentiated Caco-2 cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. The gut-bone-inflammation axis: intestinal barrier disruption as a central driver of osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 6 institutions in 6 countries.

Luz Del Carmen Martínez-SánchezDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Phuong Anh NgoDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Rashmita PradhanDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Lukas-Sebastian BeckerDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
David BoehringerDepartment of Physics, University of Erlangen Nuremberg, Erlangen, Bayern, Germany.
Despina SoteriouMax-Planck Zentrum für Physik und Medizin, Erlangen, Germany.
Marketa KubankovaMax-Planck Zentrum für Physik und Medizin, Erlangen, Germany.
Christine SchweitzerMax-Planck Zentrum für Physik und Medizin, Erlangen, Germany.
Tatyana KochDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Veronika ThonnDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Lena ErkertDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Iris StolzerDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Claudia GüntherDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Christoph BeckerDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.ORCID 0000-0002-1388-1041
Benno WeigmannDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.ORCID 0000-0002-2398-0844
Monika KlewerDepartment of Nephropathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Bayern, Germany.
Christoph DanielDepartment of Nephropathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Bayern, Germany.
Kerstin AmannDepartment of Nephropathology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Bayern, Germany.
Stefan TenzerUniversity Medical Center Mainz, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Rheinland-Pfalz, Germany.
Raja AtreyaDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Martin BergoDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Cord BrakebuschBiotech Research & Innovation Centre, University of Copenhagen, Kobenhavn, Hovedstaden, Denmark.
Alastair J M WatsonGastroenterology, University of East Anglia, Norwich, Norfolk, UK.ORCID 0000-0003-3326-0426
Jochen GuckDepartment of Physics, University of Erlangen Nuremberg, Erlangen, Bayern, Germany.
Ben FabryDepartment of Physics, University of Erlangen Nuremberg, Erlangen, Bayern, Germany.
Imke AtreyaDepartment of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.
Markus F Neurath *Department of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany.ORCID 0000-0003-4344-1474
Rocío López-Posadas *Department of Medicine 1, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany Rocio.Lopez-Posadas@uk-erlangen.de.ORCID 0000-0002-2398-5864
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEMax Planck Institute for the Science of Light · DEJohannes Gutenberg University Mainz · DEKarolinska Institutet · SEUniversity of Copenhagen · DKUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIncreased apoptotic shedding has been linked to intestinal barrier dysfunction and development of inflammatory bowel diseases (IBD). In contrast, physiological cell shedding allows the renewal of the epithelial monolayer without compromising the barrier function. Here, we investigated the role of live cell extrusion in epithelial barrier alterations in IBD.

designTaking advantage of conditional GGTase and RAC1 knockout mice in intestinal epithelial cells (

resultsEpithelial

conclusionImpaired epithelial RAC1 function causes cell overcrowding and epithelial leakage thus inducing chronic intestinal inflammation. Epithelial RAC1 emerges as key regulator of cytoskeletal dynamics, cell mechanics and intestinal cell shedding. Modulation of RAC1 might be exploited for restoration of epithelial integrity in the gut of patients with IBD.

Indexed as

CytoskeletonInflammatory Bowel DiseasesAnimalsEpithelial CellsHumansInflammationIntestinal MucosaMiceMice, KnockoutNeuropeptidesrac1 GTP-Binding ProteinNeuropeptidesrac1 GTP-Binding ProteinRAC1 protein, humanRac1 protein, mouseactin cytoskeletonepithelial barrierIBDintestinal epitheliumtight junction

Identifiers

PMID35241625
PMCPMC9872254
OpenAlexW4214906937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.